June 30, 2026 a 09:00 am
KVUE: Analysts Ratings - Kenvue Inc.
Kenvue Inc., a dominant player in the consumer health market, showcases a steady performance with a significant inclination towards a 'Hold' rating among analysts. Despite its diversified product range across key health sectors such as self-care and skin health, analyst sentiment reflects a cautious optimism. This mirrors a focus on stability more than aggressive growth.
Historical Stock Grades
Over the recent months, Kenvue Inc. has maintained a stable analyst rating, predominantly falling in the 'Hold' category. This indicates a general consensus of potential steadiness in performance rather than aggressive opportunities.
| Rating | Count | Indicator |
|---|---|---|
| Strong Buy | 1 | |
| Buy | 1 | |
| Hold | 12 | |
| Sell | 0 | |
| Strong Sell | 0 |
Sentiment Development
Analyzing the sentiment development reveals a strong inclination towards 'Hold' ratings over the past months, underpinning a conservative stance among analysts.
- Minimal changes in the count for 'Strong Buy' and 'Buy' categories.
- 'Hold' category remains dominant, suggesting consistent cautious sentiment.
- No significant upswing or drop in 'Sell' or 'Strong Sell' categories, indicating stable confidence levels.
Percentage Trends
Throughout the timeline from December 2024 to June 2026, Kenvue Inc. has seen a reduction in 'Strong Buy' from 3 to 1, while the 'Hold' category has increasingly dominated.
- The concentration in 'Hold' ratings points to growing analyst conservatism.
- Little change observed in 'Buy', indicating a stabilized short-term outlook.
- The decline in 'Strong Buy' offers insights into moderated expectations on growth potential.
- 'Sell' and 'Strong Sell' categories hold negligible influence, suggesting no immediate concerns of value depreciation.
Latest Analyst Recommendations
Recent analyst reports consistently suggest maintaining the current view, with no new direction, keeping 'Neutral' and 'Equal Weight' standings in focus.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-04-15 | Neutral | Neutral | Citigroup |
| 2026-04-14 | Equal Weight | Equal Weight | Barclays |
| 2026-04-07 | Neutral | Neutral | UBS |
| 2026-03-06 | Equal Weight | Equal Weight | Barclays |
| 2026-02-18 | Neutral | Neutral | Citigroup |
Analyst Recommendations with Change of Opinion
A notable shift in opinion is observed with some downgrades from 'Buy' to 'Hold', reflecting caution regarding aggressive short-term opportunities.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-01-30 | Hold | Buy | Jefferies |
| 2025-10-29 | Hold | Buy | Canaccord Genuity |
| 2025-09-26 | Buy | Neutral | Rothschild & Co |
| 2025-01-06 | Overweight | Neutral | Piper Sandler |
| 2024-12-12 | Hold | Buy | Deutsche Bank |
Interpretation
The prevalent 'Hold' ratings indicate a consensus on Kenvue Inc.'s steady but unremarkable market position, highlighting neither aggressive growth expectations nor impending challenges. The ongoing downgrades from 'Buy' to 'Hold' suggest a neutral market sentiment with limited upside potential. The stable lack of 'Sell' signals offers a degree of confidence in the company’s resilience amid market volatility.
Conclusion
Kenvue Inc. faces a consolidated analyst outlook that prioritizes stability over speculative growth, with hold recommendations prevailing. The company's diverse product offerings support a robust defensive strategy, though the lack of significant buy impetus shapes a conservative forecast. Evaluating the past year, the decline in strong buy ratings underscores a tempered enthusiasm within the analyst community, while ongoing downgrades spotlight cautious sector performance expectations. For investors, this translates into a reliable, albeit slow-growing, investment proposition.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years